Well, the company has talked in its press releases about the exact opposite. Also, I am pretty confident that Dixie Elixirs and MJNA will conclude their arbitration with a split. Earlier today, Wealth4Life suggested that MJNA would retain the "Botanicals" line but not Elixirs, and this seems like a reasonable expectation.
There is nothing wrong with being a CBD company, especially if you have a head start over the rest of the industry.